Denali Therapeutics
This role safeguards the quality and continuity of biosample data that underpins clinical development and regulatory submissions across Phase I–IV trials. It translates biospecimen strategy into consistent, compliant execution across specialty laboratory vendors, protecting data integrity and program timelines. The position leads vendor oversight and cross-functional alignment to ensure inspection readiness and enable confident, data-driven development decisions.
Headquarters
South San Francisco, California, United States
Company Size
201-500 employees
Founded
2015
Denali Therapeutics brings the power of biotherapeutics to the whole body, including the brain. We discover, develop and deliver medicines for people living with serious diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Denali Therapeutics.
63% above the average for this role